These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36004342)

  • 21. Quality of life in Cushing's syndrome.
    Santos A; Crespo I; Aulinas A; Resmini E; Valassi E; Webb SM
    Pituitary; 2015 Apr; 18(2):195-200. PubMed ID: 25647329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of functional remission in Cushing's syndrome.
    Vermalle M; Alessandrini M; Graillon T; Paladino NC; Baumstarck K; Sebag F; Dufour H; Brue T; Castinetti F
    Endocrine; 2018 Sep; 61(3):518-525. PubMed ID: 30019306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Volumetric magnetic resonance imaging analysis in patients with short-term remission of Cushing's disease.
    Jiang H; Ren J; He NY; Liu C; Sun YH; Jian FF; Bian LG; Shen JK; Yan FH; Pan SJ; Sun QF
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):367-374. PubMed ID: 28543178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered neural processing of emotional faces in remitted Cushing's disease.
    Bas-Hoogendam JM; Andela CD; van der Werff SJ; Pannekoek JN; van Steenbergen H; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Biermasz NR; van der Wee NJ; Pereira AM
    Psychoneuroendocrinology; 2015 Sep; 59():134-46. PubMed ID: 26092780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological Functioning in Patients with Cushing's Disease and Cushing's Syndrome.
    Siegel S; Kirstein CF; Grzywotz A; Hütter BO; Wrede KH; Kuhna V; Kreitschmann-Andermahr I
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):194-202. PubMed ID: 32992348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study.
    Dimopoulou C; Geraedts V; Stalla GK; Sievers C
    BMJ Open; 2015 Mar; 5(3):e006134. PubMed ID: 25818269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection.
    Peri A; Bemporad D; Parenti G; Luciani P; Serio M; Mannelli M
    Eur J Endocrinol; 2001 Nov; 145(5):605-11. PubMed ID: 11720879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Tuebingen CD-25 Inventory as a Measure of Postoperative Health-Related Quality of Life in Patients Treated for Cushing's Disease.
    Milian M; Kreitschmann-Andermahr I; Siegel S; Kleist B; Führer-Sakel D; Honegger J; Buchfelder M; Psaras T
    Neuroendocrinology; 2015; 102(1-2):60-7. PubMed ID: 25968090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire.
    Webb SM; Badia X; Barahona MJ; Colao A; Strasburger CJ; Tabarin A; van Aken MO; Pivonello R; Stalla G; Lamberts SW; Glusman JE
    Eur J Endocrinol; 2008 May; 158(5):623-30. PubMed ID: 18426820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic Drugs in Patients with Cushing's Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study.
    Bengtsson D; Ragnarsson O; Berinder K; Dahlqvist P; Edén Engström B; Ekman B; Höybye C; Burman P; Wahlberg J
    J Clin Endocrinol Metab; 2021 May; 106(6):1750-1760. PubMed ID: 33567076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with Cushing's syndrome in remission.
    Stomby A; Salami A; Dahlqvist P; Evang JA; Ryberg M; Bollerslev J; Olsson T; Johannsson G; Ragnarsson O
    Eur J Endocrinol; 2019 May; 180(5):329-338. PubMed ID: 30939453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.
    Siegel S; Milian M; Kleist B; Psaras T; Tsiogka M; Führer D; Koltowska-Häggström M; Honegger J; Müller O; Sure U; Menzel C; Buchfelder M; Kreitschmann-Andermahr I
    Pituitary; 2016 Dec; 19(6):590-600. PubMed ID: 27590785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in Evaluation of Cognitive Impairment in Patients with Cushing's Disease.
    Mao WY; You H; Xing B; Zhu HJ; Feng F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Dec; 38(6):735-738. PubMed ID: 28065244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission.
    Ragnarsson O; Glad CA; Berglund P; Bergthorsdottir R; Eder DN; Johannsson G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1803-7. PubMed ID: 24915124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing's disease.
    Heald A; Parr C; Gibson C; O'driscoll K; Fowler H
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):490-7. PubMed ID: 17115346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular Health in Patients in Remission of Cushing's Syndrome Is Comparable With That in BMI-Matched Controls.
    Wagenmakers MA; Roerink SH; Schreuder TH; Plantinga TS; Holewijn S; Thijssen DH; Smit JW; Rongen GA; Pereira AM; Wagenmakers AJ; Netea-Maier RT; Hermus AR
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4142-4150. PubMed ID: 27552540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging cerebral microbleeds in Cushing's disease evaluated by quantitative susceptibility mapping: an observational cross-sectional study.
    Jiang H; Yang W; Sun Y; Yan F; Sun Q; Wei H; Bian LG
    Eur J Endocrinol; 2021 Apr; 184(4):565-574. PubMed ID: 33730688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related Quality of Life in Patients After Treatment of Cushing's Disease.
    Nader S; Burkhardt T; Vettorazzi E; Milian M; Aberle J; Petersenn S; Flitsch J
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):187-91. PubMed ID: 27008635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.
    Webb SM; Ware JE; Forsythe A; Yang M; Badia X; Nelson LM; Signorovitch JE; McLeod L; Maldonado M; Zgliczynski W; de Block C; Portocarrero-Ortiz L; Gadelha M
    Eur J Endocrinol; 2014 Jul; 171(1):89-98. PubMed ID: 24760537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.